{
    "Variants Include": [
      {
        "Gene": "SNCA",
        "variants": [
          {
            "HGVS": "NM_000345.4:c.157G>A",
            "cDNA Change": {
              "transcript": "NM_000345.4",
              "ref": "G",
              "alt": "A",
              "position": "157"
            },
            "Protein Change": {
              "ref": "A",
              "alt": "T",
              "position": "53"
            },
            "Description in input context": "A53T"
          },
          {
            "HGVS": "NM_000345.4:c.260G>A",
            "cDNA Change": {
              "transcript": "NM_000345.4",
              "ref": "G",
              "alt": "A",
              "position": "260"
            },
            "Protein Change": {
              "ref": "S",
              "alt": "N",
              "position": "87"
            },
            "Description in input context": "S87N"
          }
        ]
      }
    ],
    "Described Disease": {
        "Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
      {
        "Assay Method": "Fluorescence analysis",
        "Material used": {
          "Material Source": "Protein variants",
          "Material Name": "Human-mouse αSynuclein chimeras",
          "Description": "Fluorescence analysis of the human-mouse variants shows that the A53T substitution dominates the growth kinetics, while the lag phase is affected by a combination of the A53T and S87N substitutions."
        },
        "Readout type": "Quantitative",
        "Readout description": [
          {
            "Variant": "NM_000345.4:c.157G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "The A53T substitution plays a key role in controlling growth rates."
          },
          {
            "Variant": "NM_000345.4:c.260G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "intermediate effect",
            "Result Description": "The S87N substitution affects the lag phase in combination with the A53T substitution."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "At least six replicates were performed on each variant."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type α-synuclein serves as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Thioflavin T (ThT) fluorescence",
        "Material used": {
          "Material Source": "Protein variants",
          "Material Name": "Human-mouse αSynuclein chimeras",
          "Description": "Kinetic measurements by ThT fluorescence experiments show that the identity of the N-terminal substitution A53T plays a key role in controlling growth rates."
        },
        "Readout type": "Quantitative",
        "Readout description": [
          {
            "Variant": "NM_000345.4:c.157G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "The A53T substitution is the dominant factor in modulating the growth rates."
          },
          {
            "Variant": "NM_000345.4:c.260G>A",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "All eight variants were measured at the same time and normalized data were used to determine the mean and standard deviation of the apparent growth rate and the lag time of each variant."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type α-synuclein serves as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Negative staining Transmission Electron Microscopy (TEM)",
        "Material used": {
          "Material Source": "Protein variants",
          "Material Name": "Human-mouse αSynuclein chimeras",
          "Description": "Fibril morphology of human-mouse chimeras was observed with negative staining TEM."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_000345.4:c.157G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "Variants with the mouse T53 residue form fibrils more rapidly than those with the human A53 residue."
          },
          {
            "Variant": "NM_000345.4:c.260G>A",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "Variants with the human A53 residue form fibrils more slowly than those with the mouse T53 residue."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type α-synuclein serves as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Nuclear Magnetic Resonance (NMR)",
        "Material used": {
          "Material Source": "Protein variants",
          "Material Name": "Human-mouse αSynuclein chimeras",
          "Description": "NMR chemical shift analysis of the monomeric forms of the human-mouse variants enables us to establish a link between the changes in the conformational properties in the region of position 53 upon mutation and the corresponding changes in growth rates."
        },
        "Readout type": "Quantitative",
        "Readout description": [
          {
            "Variant": "NM_000345.4:c.157G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "The presence of a threonine residue at position 53 increases local helical propensity, which correlates with faster growth rates. The alanine residue in humans may minimize Parkinson’s disease risk by favoring β-sheet conformations that slow aggregation."
          },
          {
            "Variant": "NM_000345.4:c.260G>A",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "N.D.",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "Duplicate triple resonance spectra collected on different machines several months apart showed that the 13Cα and 13Cβ chemical shifts have a standard deviation of 0.07 ppm."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type α-synuclein serves as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      }
    ]
  }